Nanomaterial-Based Drug Delivery in Cancer Therapy
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Nanobiotechnology and Biofabrication".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 8
Special Issue Editors
Interests: nanomedicine; polymer synthesis; lipid-based nanoparticles; biopharmaceutics; neurodegenerative disease; biomaterials; in vitro product performance; PBPK modeling and simulations
Special Issues, Collections and Topics in MDPI journals
Interests: nanocarriers; polymers; biomaterials; inorganic materials; drug delivery; gene therapy; diagnostics; cancer; inflammatory diseases; genetic disorders
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutical formulation technology; PKPD modelling; cell culture based works; nanoformulation development and evaluation; drug dissolution studies; analytical, bioanalytical method development and validations
Special Issue Information
Dear Colleagues,
Recent advancements in nanomedicine have significantly transformed cancer therapy by providing targeted drug delivery, enhanced treatment efficacy, and reduced off-target toxicity. Nanomaterial-based drug delivery systems can be engineered to deliver chemotherapeutic agents specifically to tumor tissues, improving drug solubility, stability, and bioavailability with reduced adverse side effects. These systems exploit the unique physicochemical properties of nanomaterials to achieve tumor-specific accumulation, presenting a promising alternative to conventional treatments.
The integration of artificial intelligence (AI) and machine learning (ML) into nanomedicine further strengthens this approach. AI/ML tools facilitate the analysis of complex biological datasets, enabling the design of personalized nanocarriers and the prediction of treatment outcomes. This synergy between nanomedicine and AI/ML is accelerating the shift toward precision oncology by optimizing formulations and identifying effective drug combinations.
This Special Issue invites original research and review articles focused on recent advances in nanomaterial-based drug delivery for cancer therapy. Topics of interest include (but are not limited to) polymeric nanoparticles, liposomes, dendrimers, solid lipid nanoparticles, micelles, inorganic nanocarriers, AI/ML applications in cancer treatment, and computational modeling approaches. We welcome contributions that explore novel approaches and insights into the future of cancer therapy through nanotechnology.
We look forward to receiving your contributions.
Dr. Venkata Krishna Kowthavarapu
Dr. Saurabh Sharma
Guest Editors
Dr. Mahipal Reddy Donthi
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterial-based drug delivery
- cancer therapy
- nanomedicine
- targeted drug delivery
- nanoparticles (polymeric/liposomes/dendrimers)
- AI/ML in oncology
- precision oncology
- nanocarriers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
